Source: BMC Oral Health. Unidade: FO
Subjects: TERAPIA A LASER, MUCOSA ORAL
ABNT
BEZINELLI, Leticia Mello et al. Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study. BMC Oral Health, v. 29, p. 6891-6902, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00520-021-06268-9. Acesso em: 20 ago. 2024.APA
Bezinelli, L. M., Corrêa, L., Kutner, J. M., Ribeiro, A. F., Hamerschlak, N., Eduardo, C. de P., et al. (2021). Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study. BMC Oral Health, 29, 6891-6902. doi:10.1007/s00520-021-06268-9NLM
Bezinelli LM, Corrêa L, Kutner JM, Ribeiro AF, Hamerschlak N, Eduardo C de P, Migliorat CA, Eduardo F de P. Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study [Internet]. BMC Oral Health. 2021 ; 29 6891-6902.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1007/s00520-021-06268-9Vancouver
Bezinelli LM, Corrêa L, Kutner JM, Ribeiro AF, Hamerschlak N, Eduardo C de P, Migliorat CA, Eduardo F de P. Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study [Internet]. BMC Oral Health. 2021 ; 29 6891-6902.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1007/s00520-021-06268-9